Set up in 2005, partnerchip was formed as spin-off from the department of functional genomics (cea, evry genopole) and is accommodated in its buildings.

The company provides services in genomic sciences using powerful platforms based on microarray technologies and provides his customers with expertise in experimental design, management of microarray platform and custom bioinformatics data analysis.

Activities range from transcriptomic analysis, genotyping, genetic wide association and linkage studies, cgh and resequencing in human diseases. The facility is dedicated to basic research, medical research and molecular diagnosis for academics, cosmetology, food and pharmaceutical industries.

PCHIP is leading R&D projects aiming at new chip-based tools dedicated to improve molecular diagnosis in various human diseases. Interests include gene expression signatures and resequencing of disease related genes.

Experience and skills in the microarray technologies field make PCHIP the partner to take in charge the microarray conception and validation steps required for the project.

Pascale is the founder of the company, he participated in the elaboration of the first human genome physical map and was in charge of the CEA microarray platform (recognised at a national level).

Sylvain graduated in 2002 of a PhD in Cell Physiology from Université Pierre et Marie Curie (Paris) working on the identification and characterisation of new genes involved in adipose tissue metabolism using differential display methods.

Then, he started a post-doctoral position in Oncology Department at sanofi-aventis aiming at the high-scale identification of differentially expressed genes from various angiogenesiis models using microarray technology.

Finally, he started to work for PartnerChip in 2005 and he is now in charge of the implementation of new technologies in the lab, the analysis of large genomic data and R&D projects.

Sylvain is in charge of the implementation of Nimblegen technology in the lab. As PartnerChip is involved as a facility for partners from the consortium that doesn't have Nimblegen technology and expertise in microarray, he will be interacting and collaborate with other lab members to carry through all experimental steps.

Linhda is a research engineer in charge of the development of proteomic services. She is involved in R&D projects (resequencing).